# Fair Pricing and Consumer Protection Act

## Original Finalized Core Structure

### Purpose

To establish enforceable, transparent, and cost-based pricing standards while eliminating exploitative pricing practices across essential industries affecting the citizens of Michigan and the United States.

—

# Section 1. Short Title

This Act shall be known and cited as the:

**“Fair Pricing and Consumer Protection Act.”**

—

# Section 2. Findings and Legislative Intent

The Legislature finds that:

1. Citizens are increasingly subjected to artificial inflation, predatory pricing, shrinkflation, manipulated supply chains, and monopolistic market behavior.

2. Essential industries have increasingly operated without sufficient transparency regarding pricing justification, resulting in excessive financial burden on working-class Americans.

3. Consumers lack meaningful visibility into how prices are determined across critical sectors including fuel, insurance, utilities, food processing, pharmaceuticals, transportation, and retail goods.

4. Existing enforcement mechanisms have proven insufficient to deter coordinated price manipulation, deceptive market conduct, and exploitative pricing behavior.

5. It is the intent of this Act to restore transparency, accountability, and cost-based pricing standards while preserving lawful free-market competition.

—

# Section 3. Definitions

## “Covered Industry”

Includes but is not limited to:

* Fuel and energy providers
* Utility companies
* Insurance providers
* Pharmaceutical manufacturers
* Food processing corporations
* Fast food corporations
* Warehouse distribution networks
* Transportation and logistics companies
* Retail chains
* Essential goods suppliers

## “Price Gouging”

The act of increasing prices beyond reasonable cost-based justification during normal or emergency market conditions.

## “Shrinkflation”

Reducing product quantity, quality, weight, or usable value while maintaining or increasing price without clear consumer disclosure.

## “Artificial Supply Restriction”

Intentional limitation of inventory, production, transportation, or distribution for the purpose of inflating market pricing.

—

# Section 4. Maximum Allowable Pricing Standards

1. No covered entity shall increase prices more than:

* 10% above the verified median market value
unless directly supported by documented increases in:
* production costs
* transportation costs
* labor costs
* material acquisition costs
* infrastructure costs

2. During declared emergencies, disasters, or supply disruptions:

* price increases shall not exceed 5% above median pricing standards.

3. All pricing increases exceeding threshold limits shall require:

* documented justification
* independent audit capability
* public filing accessibility where legally permissible

—

# Section 5. Mandatory Pricing Transparency

All covered entities shall:

* maintain auditable financial records
* disclose pricing methodologies
* report quarterly pricing adjustments
* provide cost-basis documentation upon regulatory request

Required reporting categories include:

* labor costs
* transportation costs
* executive compensation
* shareholder distributions
* manufacturing costs
* import/export fluctuations
* supply chain interruptions

—

# Section 6. Insurance Industry Accountability

1. Insurance companies operating within Michigan shall provide actuarial justification for:

* premium increases
* deductible increases
* coverage reductions

2. Rate increases must demonstrate legitimate cost necessity and may not be based solely upon:

* projected profit expansion
* speculative loss modeling
* artificial market manipulation

3. The state shall establish enhanced actuarial review standards to ensure:

* pricing fairness
* market competition
* consumer protection

—

# Section 7. Pharmaceutical and Medical Pricing Controls

1. Pharmaceutical pricing increases exceeding established inflationary benchmarks shall require:

* documented manufacturing cost analysis
* research and development justification
* supply chain verification

2. Artificial restriction of life-saving medication availability for pricing leverage shall constitute:

* unlawful market manipulation

3. Generic suppression practices intended to preserve monopolistic pricing structures shall be subject to enforcement review.

—

# Section 8. Anti-Shrinkflation Requirements

1. Products reduced in:

* quantity
* weight
* concentration
* usable value

must clearly display:

* “Reduced Product Quantity”
or equivalent consumer-visible disclosure.

2. Failure to disclose material reduction shall constitute deceptive trade practice enforcement eligibility.

—

# Section 9. Anti-Monopoly and Market Manipulation Enforcement

The following practices are prohibited:

* artificial supply shortages
* coordinated price manipulation
* deceptive scarcity marketing
* collusive pricing agreements
* hidden fee expansion
* deceptive subscription conversion systems
* exploitative emergency pricing

—

# Section 10. Office of Fair Pricing Oversight

A regulatory oversight division shall be established for:

* pricing investigations
* market auditing
* consumer complaint review
* emergency enforcement actions
* public reporting transparency

The office shall publish:

* quarterly industry reports
* pricing trend analysis
* enforcement actions
* public consumer advisories

—

# Section 11. Enforcement Authority

Primary enforcement authority shall include:

* Federal Trade Commission (FTC)
* Department of Justice (DOJ)
* State Attorney General Offices
* Consumer Protection Divisions

—

# Section 12. Civil and Criminal Penalties

Violations may result in:

* fines up to three times unlawful profits
* mandatory restitution
* operational restrictions
* suspension of licenses
* executive liability
* criminal prosecution where fraud or coordinated manipulation exists

Repeat offenders may be subject to:

* expanded federal oversight
* anti-trust review
* forced operational restructuring

—

# Section 13. Prohibition on Legislative or Regulatory Shielding

No corporation, entity, agency, or industry shall use:

* lobbying influence
* regulatory exemptions
* legislative carve-outs
* administrative loopholes

to bypass the enforcement intent of this Act.

Any exemption must:

* be publicly disclosed
* undergo independent review
* include documented justification

—

# Section 14. Consumer Right of Action

Consumers directly harmed by violations under this Act may:

* pursue civil damages
* participate in class-action litigation
* seek injunctive relief
* request disclosure investigations

—

# Section 15. Public Transparency Reporting

All enforcement actions, settlements, penalties, and investigations shall be publicly reportable except where:

* active criminal investigations
* national security limitations
* protected personal information restrictions
apply.

—

# Section 16. Effective Date

This Act shall take effect:

* 180 days following enactment

allowing regulatory agencies and covered industries sufficient implementation preparation time.